| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
A pharmacovigilance study of adverse events associated with polycythemia vera treatments using the FDA Adverse Event Reporting System (FAERS) database
|
Reeves, Brandi N.
|
|
|
104 |
7 |
p. 3669-3679
|
artikel
|
| 2 |
Assessing serum thrombopoietin for enhanced diagnosis of ITP, AA, and MDS using machine learning: A retrospective cohort study
|
Zhu, Guoqing
|
|
|
104 |
7 |
p. 3631-3645
|
artikel
|
| 3 |
Autologous stem cell transplantation with thiotepa, busulfan, and cyclophosphamide conditioning in patients with central nervous system lymphoma: a phase II study
|
Kim, Dong Hyun
|
|
|
104 |
7 |
p. 3843-3854
|
artikel
|
| 4 |
Avapritinib monotherapy induces rapid and deep remission of heavily treated, KIT D816H-mutated t(8;21) acute myeloid leukemia, a case report and literature review
|
Getz, Ted M.
|
|
|
104 |
7 |
p. 3889-3892
|
artikel
|
| 5 |
Brentuximab vedotin plus CHP-like regimen for the first-line treatment of PTCL patients: a real-world single center study
|
Guan, Fangshu
|
|
|
104 |
7 |
p. 3745-3751
|
artikel
|
| 6 |
Cladribine and medium-dose cytarabine intensified busulfan plus cyclophosphamide conditioning regimen for adults high-risk B-cell acute lymphoblastic leukemia
|
Cheng, Tingting
|
|
|
104 |
7 |
p. 3753-3762
|
artikel
|
| 7 |
Clinical and prognostic significance of whole blood Epstein-Barr virus DNA in patients with primary hemophagocytic lymphohistiocytosis: a retrospective observational study from China
|
Dou, Liurui
|
|
|
104 |
7 |
p. 3597-3607
|
artikel
|
| 8 |
Clinical significance of C-reactive protein/platelet ratio from diagnosis to allogeneic hematopoietic stem cell transplantation in acute myeloid leukemia
|
Izumi, Akihiko
|
|
|
104 |
7 |
p. 3733-3743
|
artikel
|
| 9 |
Daratumumab plus bortezomib and dexamethasone as a bridge to allogeneic transplantation in refractory T-cell lymphoblastic lymphoma
|
Maraglino, Alessio Maria Edoardo
|
|
|
104 |
7 |
p. 3875-3879
|
artikel
|
| 10 |
Distinct structural and numerical chromosome abnormalities determine the MYC status in diffuse large B-Cell lymphoma and help differentiate from Burkitt lymphoma: a cytogenetic data analysis using unsupervised and AI-driven prediction models
|
García, Rolando
|
|
|
104 |
7 |
p. 3763-3777
|
artikel
|
| 11 |
Efficacy and safety analysis of different treatment regimens in newly diagnosed acute promyelocytic leukemia
|
Zhang, Di
|
|
|
104 |
7 |
p. 3703-3711
|
artikel
|
| 12 |
Efficacy and safety of Glofitamab in patients with R/R DLBCL in real life setting– a retrospective study
|
Gurion, Ronit
|
|
|
104 |
7 |
p. 3821-3827
|
artikel
|
| 13 |
Exploring thromboembolic risk factors in polycythemia vera: from current evidence to PROSPERO study design
|
De Stefano, Valerio
|
|
|
104 |
7 |
p. 3553-3566
|
artikel
|
| 14 |
Factors influencing prenatal diagnosis of deletional hemoglobin H disease in thalassemia prevention and control program, Southern China
|
Chen, Ruirui
|
|
|
104 |
7 |
p. 3567-3574
|
artikel
|
| 15 |
Feasibility analysis of metabolic parameters based on baseline 18F-FDG PET/CT to predict heterogeneity and recurrence of diffuse large B-cell lymphoma
|
Ge, Fan
|
|
|
104 |
7 |
p. 3803-3819
|
artikel
|
| 16 |
Feasibility of allogeneic stem cell transplantation (HSCT) in patients with acute myeloid leukemia previously treated with CPX-351: report from a single center
|
Giammarco, Sabrina
|
|
|
104 |
7 |
p. 3855-3861
|
artikel
|
| 17 |
First report of B-lymphoblastic leukemia harboring LRRFIP1::FGFR1 fusion: expanding the clinical spectrum of myeloid/lymphoid neoplasms with tyrosine kinase gene fusions
|
Chen, Xue
|
|
|
104 |
7 |
p. 3899-3902
|
artikel
|
| 18 |
Genotype-dependent albuminuria in adult sickle cell disease in Kinshasa
|
Engole, Yannick Mompango
|
|
|
104 |
7 |
p. 3585-3595
|
artikel
|
| 19 |
Good response to oxymetholone in adult aplastic anemia
|
Chaipokam, Jindaratn
|
|
|
104 |
7 |
p. 3609-3618
|
artikel
|
| 20 |
High-dose romiplostim for donor-type aplasia
|
Hosokawa, Kohei
|
|
|
104 |
7 |
p. 3863-3867
|
artikel
|
| 21 |
Identification of a novel complex variant in a patient involving the α-globin gene cluster by third-generation sequencing
|
Liu, Hui
|
|
|
104 |
7 |
p. 3619-3629
|
artikel
|
| 22 |
IGH/IGK gene rearrangement in the diagnosis of B-cell non-Hodgkin lymphoma: experience from three centers
|
Yang, Ke
|
|
|
104 |
7 |
p. 3779-3789
|
artikel
|
| 23 |
Immunotherapy-associated hemostatic abnormalities: bleeding and thrombotic complications
|
Li, Yingying
|
|
|
104 |
7 |
p. 3537-3551
|
artikel
|
| 24 |
Inotuzumab therapy resulted in molecular remission of relapsed/resistant B-cell acute lymphoblastic leukemia with BCR::ABL1 Lys404Glu mutation
|
Lewandowski, Krzysztof
|
|
|
104 |
7 |
p. 3893-3898
|
artikel
|
| 25 |
Ixazomib-lenalidomid-dexamethasone (IRd) in relapsed refractory multiple myeloma (RRMM)—multicenter real-world analysis from Germany and comparative review of the literature
|
Löffler, Hanna
|
|
|
104 |
7 |
p. 3713-3722
|
artikel
|
| 26 |
Prognostic significance of angiogenesis-associated molecules and Immunologic characteristic in elderly patients with acute myeloid leukemia
|
Chen, Can
|
|
|
104 |
7 |
p. 3681-3691
|
artikel
|
| 27 |
Rethinking bone marrow biopsy: is PET/CT enough for staging low-grade follicular lymphomas?
|
Chen, Yan-Yan
|
|
|
104 |
7 |
p. 3791-3801
|
artikel
|
| 28 |
Romiplostim versus Recombinant human thrombopoietin in umbilical cord blood transplantation: a single-center retrospective study
|
Ding, Yuntian
|
|
|
104 |
7 |
p. 3837-3842
|
artikel
|
| 29 |
Safe administration of venetoclax-obinutuzumab in a chronic lymphocytic leukemia patient with Brugada syndrome
|
Cardinali, Valeria
|
|
|
104 |
7 |
p. 3869-3873
|
artikel
|
| 30 |
Safety of low-dose radiotherapy in newly diagnosed stage I/II extranodal NK/T-cell lymphoma: a single-center retrospective analysis
|
Hao, Shifeng
|
|
|
104 |
7 |
p. 3723-3731
|
artikel
|
| 31 |
Secondary neoplasms in mycosis fungoides: evaluating risk factors and phototherapy impact in a comparative study
|
Acar, Ayda
|
|
|
104 |
7 |
p. 3829-3836
|
artikel
|
| 32 |
SGK1 repression by WT1 may confer a survival advantage to leukemic cells under stress conditions
|
Rubio, Miguel A.
|
|
|
104 |
7 |
p. 3655-3667
|
artikel
|
| 33 |
Subclonal emergence of polycythemia vera, chronic myelomonocytic leukemia, and chronic myeloid leukemia
|
Tran Quang, Violaine
|
|
|
104 |
7 |
p. 3881-3887
|
artikel
|
| 34 |
Treatment burden in patients with paroxysmal nocturnal hemoglobinuria: an in-depth interview survey
|
Ueda, Yasutaka
|
|
|
104 |
7 |
p. 3575-3584
|
artikel
|
| 35 |
Validation of the Spanish version of the EORTC QLQ-CML24 questionnaire for assessment of health-related quality of life in patients with chronic myeloid leukemia
|
Lopez-Fernández, Elisa
|
|
|
104 |
7 |
p. 3693-3702
|
artikel
|
| 36 |
VINCENT: A randomized-controlled trial evaluating venetoclax plus azacitidine versus intensive chemotherapy in patients with newly diagnosed, NPM1-mutated AML
|
Kretschmer, Lydia
|
|
|
104 |
7 |
p. 3647-3654
|
artikel
|
Tijdschrift beschrijving